Are you Dr. Kutok?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
75 Francis St
"# Brigham"
Boston, MA 02115Phone+1 617-732-5714
Summary
- Dr. Jeffery Kutok, MD is a board certified pathologist in Boston, Massachusetts. He is an Associate Professor of Pathology at Brigham and Women's Hospital.
Certifications & Licensure
American Board of Pathology Anatomic Pathology- American Board of Pathology Hematology
Publications & Presentations
PubMed
- EZH2 Cooperates with BRD4-NUT to Drive NUT Carcinoma Growth by Silencing Key Tumor Suppressor Genes.Yeying Huang, R Taylor Durall, Nhi M Luong, Hans J Hertzler, Julianna Huang
Cancer Research. 2023-12-01 - 2 citationsEZH2 synergizes with BRD4-NUT to drive NUT carcinoma growth through silencing of key tumor suppressor genes.Yeying Huang, R Taylor Durall, Nhi M Luong, Hans J Hertzler, Julianna Huang
Biorxiv. 2023-08-16 - 2 citationsDuvelisib Eliminates CLL B Cells, Impairs CLL-Supporting Cells, and Overcomes Ibrutinib Resistance in a Xenograft Model.Shih-Shih Chen, Jacqueline C Barrientos, Gerardo Ferrer, Morgan King-Richards, Yu-Ju Chen
Clinical Cancer Research. 2023-05-15
Press Mentions
Epizyme Presents Preclinical Data and Phase 1/1b Trial Design on the Company’s SETD2 Inhibitor, EZM0414, at the 2021 ASH Annual MeetingDecember 11th, 2021
Epizyme Hires Kutok as CSO to Find New Uses for TazverikMarch 20th, 2020- Chutes & Ladders—Bristol Myers Squibb Appoints Mily to Strategy LeadMarch 20th, 2020
- Join now to see all
